Cargando…
A Historical Cohort Study on the Efficacy of Glucocorticoids and Riboflavin Among Patients with Late-onset Multiple Acyl-CoA Dehydrogenase Deficiency
BACKGROUND: Late-onset multiple acyl-CoA dehydrogenase deficiency (MADD) is the most common type of lipid storage myopathies in China. Most patients with late-onset MADD are well responsive to riboflavin. Up to now, these patients are often treated with glucocorticoids as the first-line drug because...
Autores principales: | Liu, Xin-Yi, Wang, Zhi-Qiang, Wang, Dan-Ni, Lin, Min-Ting, Wang, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799539/ https://www.ncbi.nlm.nih.gov/pubmed/26830983 http://dx.doi.org/10.4103/0366-6999.173438 |
Ejemplares similares
-
Late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency (MADD): case reports and epidemiology of ETFDH gene mutations
por: Chen, Wei, et al.
Publicado: (2019) -
Characterization of 31 Patients with Riboflavin-Responsive Multiple acyl-CoA Dehydrogenase Deficiency
por: Zhang, Jinru, et al.
Publicado: (2022) -
Novel ETFDH mutations in four cases of riboflavin responsive multiple acyl-CoA dehydrogenase deficiency
por: Fan, Xin, et al.
Publicado: (2018) -
Combined isobutyryl‐CoA and multiple acyl‐CoA dehydrogenase deficiency in a boy with altered riboflavin homeostasis
por: Tummolo, Albina, et al.
Publicado: (2022) -
Late Onset Multiple Acyl-CoA Dehydrogenase Deficiency: A Rare Treatable Neurometabolic Disorder
por: Korula, Sophy, et al.
Publicado: (2022)